Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867 Johnson Johnson JNJ Dips 107 as Defensive Stock Tests Key Support Levels Innovative Industrial Properties IIPR Gains 119 as Shares Test Midpoint Between Key Support and Resistance Levels Sequans Communications SQNS Gains 37 as Shares Test Key Resistance